Strs Ohio Takes $6.69 Million Position in Masimo Corporation $MASI

Key Points

• Strs Ohio has invested approximately $6.69 million in Masimo Corporation, acquiring over 40,000 shares in the first quarter, representing a 0.07% ownership stake in the company.
• Masimo reported quarterly earnings of $1.33 EPS, exceeding analyst expectations, with revenue increasing by 7.7% year-over-year to $370.9 million.
• Institutional investors and hedge funds hold a substantial 85.96% of Masimo's stock, reflecting strong interest among large financial entities.

Strs Ohio acquired a new position in Masimo Corporation (NASDAQ:MASI - Free Report) during the first quarter, according to the company in its most recent filing with the SEC. The fund acquired 40,135 shares of the medical equipment provider's stock, valued at approximately $6,686,000. Strs Ohio owned approximately 0.07% of Masimo at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in MASI. Twin Tree Management LP acquired a new position in Masimo in the 1st quarter worth $29,000. Farther Finance Advisors LLC boosted its holdings in Masimo by 128.9% in the first quarter. Farther Finance Advisors LLC now owns 206 shares of the medical equipment provider's stock worth $35,000 after purchasing an additional 116 shares during the period. NBC Securities Inc. acquired a new position in Masimo in the first quarter worth $61,000. UMB Bank n.a. lifted its stake in Masimo by 134.0% in the first quarter. UMB Bank n.a. now owns 447 shares of the medical equipment provider's stock valued at $74,000 after buying an additional 256 shares during the last quarter. Finally, Quarry LP lifted its stake in Masimo by 253.5% in the first quarter. Quarry LP now owns 449 shares of the medical equipment provider's stock valued at $75,000 after buying an additional 322 shares during the last quarter. Institutional investors and hedge funds own 85.96% of the company's stock.

Masimo Price Performance

MASI stock traded down $2.57 during trading on Friday, hitting $140.43. The company had a trading volume of 1,106,202 shares, compared to its average volume of 584,385. Masimo Corporation has a fifty-two week low of $113.54 and a fifty-two week high of $194.88. The company has a current ratio of 2.14, a quick ratio of 1.61 and a debt-to-equity ratio of 0.57. The firm has a market capitalization of $7.63 billion, a price-to-earnings ratio of -16.48 and a beta of 1.23. The business has a 50 day moving average of $150.14 and a 200 day moving average of $157.93.

Masimo (NASDAQ:MASI - Get Free Report) last issued its quarterly earnings results on Tuesday, August 5th. The medical equipment provider reported $1.33 earnings per share for the quarter, beating analysts' consensus estimates of $1.22 by $0.11. Masimo had a negative net margin of 24.85% and a positive return on equity of 26.54%. The company had revenue of $370.90 million during the quarter, compared to the consensus estimate of $368.65 million. During the same period in the prior year, the company earned $0.86 EPS. Masimo's revenue was up 7.7% on a year-over-year basis. As a group, research analysts predict that Masimo Corporation will post 4.1 earnings per share for the current year.

Analyst Ratings Changes

A number of equities research analysts have issued reports on the company. Wall Street Zen cut Masimo from a "buy" rating to a "hold" rating in a research note on Friday, May 30th. BTIG Research reiterated a "buy" rating and issued a $198.00 target price on shares of Masimo in a research note on Thursday, September 11th. Zacks Research raised Masimo from a "hold" rating to a "strong-buy" rating in a research note on Wednesday, September 3rd. Finally, Piper Sandler lifted their target price on Masimo from $200.00 to $210.00 and gave the company an "overweight" rating in a research note on Wednesday, August 6th. One equities research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and one has issued a Hold rating to the company's stock. Based on data from MarketBeat, the stock has an average rating of "Buy" and a consensus price target of $194.60.

Insiders Place Their Bets

In other Masimo news, Director William R. Jellison purchased 3,000 shares of the business's stock in a transaction on Monday, August 11th. The stock was bought at an average cost of $145.98 per share, with a total value of $437,940.00. Following the acquisition, the director owned 4,790 shares of the company's stock, valued at $699,244.20. The trade was a 167.60% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is available through this hyperlink. Insiders own 9.70% of the company's stock.

Masimo Company Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.